J. Vander, E. Gaston, and T. Dawber, Significance of Solitary Nontoxic Thyroid Nodules, New England Journal of Medicine, vol.251, issue.24, pp.970-973, 1954.
DOI : 10.1056/NEJM195412092512403

H. Gharib and E. Papini, Thyroid Nodules: Clinical Importance, Assessment, and Treatment, Endocrinology and Metabolism Clinics of North America, vol.36, issue.3, pp.707-742, 2007.
DOI : 10.1016/j.ecl.2007.04.009

J. Vander, E. Gaston, and T. Dawber, The Significance of Nontoxic Thyroid Nodules, Annals of Internal Medicine, vol.69, issue.3, pp.537-577, 1968.
DOI : 10.7326/0003-4819-69-3-537

W. Tunbridge, D. Evered, R. Hall, D. Appleton, M. Brewis et al., THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY, Clinical Endocrinology, vol.23, issue.6, pp.481-93, 1977.
DOI : 10.1016/S0140-6736(70)90709-9

M. Vanderpump, W. Tunbridge, J. French, D. Appleton, D. Bates et al., The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey, Clinical Endocrinology, vol.7, issue.1, pp.55-68, 1995.
DOI : 10.1002/sim.4780120902

E. Mazzaferri, Management of a solitary thyroid nodule, N Engl J Med Feb, vol.25328, issue.8, pp.553-562, 1993.

A. Brander, P. Viikinkoski, J. Nickels, and L. Kivisaari, Thyroid gland: US screening in a random adult population., Radiology, vol.181, issue.3, pp.683-690, 1991.
DOI : 10.1148/radiology.181.3.1947082

W. Scheible, G. Leopold, V. Woo, and B. Gosink, High-Resolution Real-Time Ultrasonography of Thyroid Nodules, Radiology, vol.133, issue.2, pp.413-420, 1979.
DOI : 10.1148/133.2.413

L. Hegedüs, S. Bonnema, and F. Bennedbaek, Management of Simple Nodular Goiter: Current Status and Future Perspectives, Endocrine Reviews, vol.24, issue.1, pp.102-134, 2003.
DOI : 10.1210/er.2002-0016

J. Woestyn, M. Afschrift, K. Schelstraete, and A. Vermeulen, Demonstration of nodules in the normal thyroid by echography, The British Journal of Radiology, vol.94, issue.696, pp.1179-82, 1985.
DOI : 10.7326/0003-4819-96-2-221

S. Ezzat, D. Sarti, D. Cain, and G. Braunstein, Thyroid incidentalomas. Prevalence by palpation and ultrasonography, Archives of Internal Medicine, vol.154, issue.16, pp.1838-1878, 1994.
DOI : 10.1001/archinte.154.16.1838

G. Tan and H. Gharib, Thyroid Incidentalomas: Management Approaches to Nonpalpable Nodules Discovered Incidentally on Thyroid Imaging, Annals of Internal Medicine, vol.126, issue.3, pp.226-257, 1997.
DOI : 10.7326/0003-4819-126-3-199702010-00009

B. Carroll, Asymptomatic thyroid nodules: incidental sonographic detection, American Journal of Roentgenology, vol.138, issue.3, pp.499-501, 1982.
DOI : 10.2214/ajr.138.3.499

URL : http://www.ajronline.org/doi/pdf/10.2214/ajr.138.3.499

L. Remontet, J. Estève, A. Bouvier, P. Grosclaude, G. Launoy et al., Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique, Feb, vol.51, issue.1, pp.3-30, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00427472

S. Périé and R. Garrel, Pathologies chirurgicales de la glande thyroïde. 2012. (Rapports de la société française d'oto-rhino-laryngologie et de chirurgie

H. Gharib, E. Papini, J. Garber, D. Duick, R. Harrell et al., American College of Endocrinology, and Associazione Medici Endocrinologi Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules ? 2016 update: appendix. Endocr Pract, pp.1-60, 2016.

E. Mazzaferri, Thyroid cancer in thyroid nodules: Finding a needle in the haystack, The American Journal of Medicine, vol.93, issue.4, pp.359-62, 1992.
DOI : 10.1016/0002-9343(92)90163-6

R. Paschke, L. Hegedüs, E. Alexander, R. Valcavi, E. Papini et al., Thyroid nodule guidelines: agreement, disagreement and need for future research, Nature Reviews Endocrinology, vol.93, issue.6, pp.354-61, 2011.
DOI : 10.1210/jc.2008-1328

S. Wiseman, A. Melck, H. Masoudi, F. Ghaidi, L. Goldstein et al., Molecular Phenotyping of Thyroid Tumors Identifies a Marker Panel for Differentiated Thyroid Cancer Diagnosis, Annals of Surgical Oncology, vol.18, issue.10, pp.2811-2837, 2008.
DOI : 10.1159/000326594

C. Chiu, S. Strugnell, O. Griffith, S. Jones, A. Gown et al., Diagnostic Utility of Galectin-3 in Thyroid Cancer, The American Journal of Pathology, vol.176, issue.5, pp.2067-81, 2010.
DOI : 10.2353/ajpath.2010.090353

I. Iurisci, N. Tinari, C. Natoli, D. Angelucci, E. Cianchetti et al., Concentrations of galectin-3 in the sera of normal controls and cancer patients, Clin Cancer Res Off J Am Assoc Cancer Res, vol.6, issue.4, pp.1389-93, 2000.

H. Inohara, T. Segawa, A. Miyauchi, T. Yoshii, S. Nakahara et al., Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies, Biochemical and Biophysical Research Communications, vol.376, issue.3, pp.605-615, 2008.
DOI : 10.1016/j.bbrc.2008.09.041

S. Saussez, D. Glinoer, G. Chantrain, F. Pattou, B. Carnaille et al., Serum Galectin-1 and Galectin-3 Levels in Benign and Malignant Nodular Thyroid Disease, Thyroid, vol.18, issue.7, pp.705-717, 2008.
DOI : 10.1089/thy.2007.0361

L. Testut and A. Latarjet, Traité d'anatomie humaine, DOIN, vol.3, 1930.

O. Trost and P. Trouilloud, Anatomie: tête, cou, nerfs crâniens et organes des sens Paris: Ellipses, 2011.

P. Bonfils, J. Chevallier, and . Anatomie, Paris: Médecine-sciences publications- Lavoisier, 2011.

P. Baque, Manuel pratique d'anatomie. Ellipses, 2008.

A. Stevens and J. Lowe, Histologie humaine, 2006.

V. Vlaeminck-guillem, Structure et physiologie thyroïdiennes. 10-002-B-10, 2011.
DOI : 10.1016/s1155-1941(11)53090-2

A. Rodriguez, B. Perron, L. Lacroix, B. Caillou, G. Leblanc et al., Identification and Characterization of a Putative Human Iodide Transporter Located at the Apical Membrane of Thyrocytes, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.7, 2002.
DOI : 10.1210/jcem.87.7.8797

L. Leenhardt, M. Bernier, M. Boin-pineau, C. Devolx, B. Maréchaud et al., Advances in diagnostic practices affect thyroid cancer incidence in France, European Journal of Endocrinology, vol.150, issue.2, pp.133-142, 2004.
DOI : 10.1530/eje.0.1500133

A. Rogel, M. Colonna, Z. Uhry, B. Lacour, C. Schwartz et al., Evolution de l'incidence du cancer de la thyroïde en France métropolitaine -Bilan sur 25 ans. Saint- Maurice : Institut de veille sanitaire 55p

K. Bilimoria, D. Bentrem, C. Ko, A. Stewart, D. Winchester et al., Extent of Surgery Affects Survival for Papillary Thyroid Cancer, Annals of Surgery, vol.246, issue.3, 2007.
DOI : 10.1097/SLA.0b013e31814697d9

M. Colonna, P. Grosclaude, L. Remontet, C. Schvartz, J. Mace-lesech et al., Incidence of thyroid cancer in adults recorded by French cancer registries (1978???1997), European Journal of Cancer, vol.38, issue.13, pp.1762-1770, 1990.
DOI : 10.1016/S0959-8049(02)00110-7

Z. Baloch and V. Livolsi, Encapsulated Follicular Variant of Papillary Thyroid Carcinoma with Bone Metastases, Modern Pathology, vol.30, issue.8, pp.861-866, 2000.
DOI : 10.1016/S0046-8177(99)90033-3

J. Liu, B. Singh, G. Tallini, D. Carlson, N. Katabi et al., Follicular variant of papillary thyroid carcinoma, Cancer, vol.26, issue.6, pp.1255-64, 2006.
DOI : 10.4158/EP.7.2.79

M. Vivero, S. Kraft, and J. Barletta, Risk Stratification of Follicular Variant of Papillary Thyroid Carcinoma, Thyroid, vol.23, issue.3, pp.273-282
DOI : 10.1089/thy.2012.0369

M. Rivera, J. Ricarte-filho, S. Patel, M. Tuttle, A. Shaha et al., Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study, Human Pathology, vol.41, issue.2, 2010.
DOI : 10.1016/j.humpath.2009.08.011

M. Rivera, J. Ricarte-filho, J. Knauf, A. Shaha, M. Tuttle et al., Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns, Modern Pathology, vol.23, issue.9, pp.1191-200, 2010.
DOI : 10.1038/modpathol.2010.112

S. Edge and C. Compton, The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM, Annals of Surgical Oncology, vol.17, issue.6, pp.1471-1475, 2010.
DOI : 10.1245/s10434-010-0985-4

B. Schmidbauer, K. Menhart, D. Hellwig, and J. Grosse, Differentiated Thyroid Cancer???Treatment: State of the Art, International Journal of Molecular Sciences, vol.159, issue.6, p.1292, 2017.
DOI : 10.1016/j.cell.2014.09.050

L. Davies and H. Welch, Increasing Incidence of Thyroid Cancer in the United States, 1973-2002, JAMA, vol.295, issue.18, pp.2164-2171, 1973.
DOI : 10.1001/jama.295.18.2164

D. Cooper, G. Doherty, B. Haugen, B. Hauger, and R. Kloos, Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer, Thyroid, vol.19, issue.11, pp.1167-214, 2009.
DOI : 10.1089/thy.2009.0110

F. Borson-chazot, S. Bardet, C. Bournaud, B. Conte-devolx, C. Corone et al., Guidelines for the management of differentiated thyroid carcinomas of vesicular origin, Ann Endocrinol, vol.69, issue.6, pp.472-86, 2008.

F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J. Smit et al., European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium, European Journal of Endocrinology, vol.154, issue.6, pp.787-803, 2006.
DOI : 10.1530/eje.1.02158

L. Leenhardt and P. Grosclaude, Epidemiology of thyroid carcinoma over the world, Ann Endocrinol. 2011, vol.72, issue.2, pp.136-184

F. Pacini, F. Cetani, P. Miccoli, F. Mancusi, C. Ceccarelli et al., Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine, World Journal of Surgery, vol.106, issue.4, pp.600-604, 1994.
DOI : 10.1007/BF00353775

M. Colonna, A. Guizard, C. Schvartz, M. Velten, N. Raverdy et al., A time trend analysis of papillary and follicular cancers as a function of tumour size: A study of data from six cancer registries in France (1983???2000), European Journal of Cancer, vol.43, issue.5, pp.891-900, 1983.
DOI : 10.1016/j.ejca.2006.11.024

URL : https://hal.archives-ouvertes.fr/inserm-00346935

D. Hughes, M. Haymart, B. Miller, P. Gauger, and G. Doherty, The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid Off J Am Thyroid Assoc, 2011.

O. Laccourreye and F. Chabolle, Les risques chirurgicaux en oto-rhino-laryngologie: information, prise en charge et prévention. Société française d'Oto-rhinolaryngologie et de chirurgie de la face et du cou, 2007.

L. Rosato, N. Avenia, P. Bernante, D. Palma, M. Gulino et al., Complications of Thyroid Surgery: Analysis of a Multicentric Study on 14,934 Patients Operated on in Italy over 5 Years, World Journal of Surgery, vol.28, issue.3, pp.271-277, 2004.
DOI : 10.1007/s00268-003-6903-1

M. Marina, M. J. Birchall, and M. , Laryngeal reinnervation for bilateral vocal fold paralysis, Current Opinion in Otolaryngology & Head and Neck Surgery, vol.19, issue.6, pp.434-442, 2011.
DOI : 10.1097/MOO.0b013e32834c7d30

J. Marie, Reinnervation: new frontiers In: Diagnostic and treatment of voice disorders, 2014.

N. Sands, R. Payne, V. Côté, M. Hier, M. Black et al., Female gender as a risk factor for transient post-thyroidectomy hypocalcemia. Otolaryngol--Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg, pp.561-565, 2011.
DOI : 10.1177/0194599811414511

D. Shoback, Clinical practice. Hypoparathyroidism, N Engl J Med Jul, vol.24359, issue.4, pp.391-403, 2008.

C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl et al., Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.8, pp.2892-2901, 2006.
DOI : 10.1210/jc.2005-2838

URL : https://hal.archives-ouvertes.fr/hal-00176664

C. Sturgeon and P. Angelos, Identification and treatment of aggressive thyroid cancers. Part 2: risk assessment and treatment, Oncol Williston Park N, 2006.

M. Muresan, P. Olivier, J. Leclère, F. Sirveaux, L. Brunaud et al., Bone metastases from differentiated thyroid carcinoma, Endocrine Related Cancer, vol.15, issue.1, 2008.
DOI : 10.1677/ERC-07-0229

Y. Nikiforov, Thyroid carcinoma: molecular pathways and therapeutic targets, Modern Pathology, vol.98, issue.2, pp.37-43, 2008.
DOI : 10.1038/nature04304

URL : http://www.nature.com/modpathol/journal/v21/n2s/pdf/modpathol200810a.pdf

J. Wémeau, J. Sadoul, M. Herbomez, H. Monpeyssen, J. Tramalloni et al., Guidelines of the French society of endocrinology for the management of thyroid nodules, Annales d'Endocrinologie, vol.72, issue.4, pp.251-81, 2011.
DOI : 10.1016/j.ando.2011.05.003

D. Cao, C. Ladsous, M. Leleurtre, E. Espiard, S. Herbomez et al., Nodules du corps thyroide, 2015.

D. Cooper, G. Doherty, B. Haugen, R. Kloos, S. Lee et al., Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce, Thyroid, vol.16, issue.2, pp.109-151, 2006.
DOI : 10.1089/thy.2006.16.109

V. Triggiani, E. Guastamacchia, B. Licchelli, and E. Tafaro, Microcalcifications and Psammoma Bodies in Thyroid Tumors, Thyroid, vol.18, issue.9, 2008.
DOI : 10.1089/thy.2008.0082

T. Rago, F. Santini, M. Scutari, A. Pinchera, and P. Vitti, Elastography: New Developments in Ultrasound for Predicting Malignancy in Thyroid Nodules, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.8, pp.2917-2939, 2007.
DOI : 10.1210/jc.2007-0641

I. Nam-goong, H. Kim, G. Gong, H. Lee, S. Hong et al., Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings, Clinical Endocrinology, vol.5, issue.1, pp.21-29
DOI : 10.1007/s002689900129

E. Horvath, S. Majlis, R. Rossi, C. Franco, J. Niedmann et al., An Ultrasonogram Reporting System for Thyroid Nodules Stratifying Cancer Risk for Clinical Management, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.5, pp.1748-51, 2009.
DOI : 10.1210/jc.2008-1724

G. Russ, C. Bigorgne, B. Royer, A. Rouxel, and M. Bienvenu-perrard, The Thyroid Imaging Reporting and Data System (TIRADS) for ultrasound of the thyroid], J Radiol, 2011.

G. Russ, B. Royer, C. Bigorgne, A. Rouxel, M. Bienvenu-perrard et al., Prospective evaluation of thyroid imaging reporting and data system on 4550 nodules with and without elastography, European Journal of Endocrinology, vol.168, issue.5, pp.649-55, 2013.
DOI : 10.1530/EJE-12-0936

M. Pitman, J. Abele, S. Ali, D. Duick, T. Elsheikh et al., Techniques for thyroid FNA: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference, Diagnostic Cytopathology, vol.106, issue.6, pp.407-431, 2008.
DOI : 10.1148/110.2.257

D. Micco and C. , Thyroid cytology: evaluation and perspectives, Ann Endocrinol, vol.54, issue.4, pp.258-63, 1993.

A. Filie, S. Asa, K. Geisinger, S. Logani, M. Merino et al., Utilization of ancillary studies in thyroid fine needle aspirates: A synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference, Diagnostic Cytopathology, vol.86, issue.6, pp.438-479, 2008.
DOI : 10.4158/EP.13.4.333

E. Cibas, E. Alexander, C. Benson, P. De-agustín, G. Doherty et al., Indications for thyroid FNA and pre-FNA requirements: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference, Diagnostic Cytopathology, vol.16, issue.6, pp.390-399, 2008.
DOI : 10.1093/ajcp/107.1.20

Z. Baloch, V. Livolsi, S. Asa, J. Rosai, M. Merino et al., Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference, Diagnostic Cytopathology, vol.96, issue.6, pp.425-462, 2008.
DOI : 10.1159/000333534

C. Dener, Complication Rates after Operations for Benign Thyroid Disease, Acta Oto-Laryngologica, vol.103, issue.6, pp.679-83, 2002.
DOI : 10.1007/BF00308993

J. Roach, K. Heller, S. Dubner, and L. Sznyter, The value of frozen section examinations in determining the extent of thyroid surgery in patients with indeterminate fineneedle aspiration cytology, Arch Otolaryngol Head Neck Surg, 2002.

S. Wiseman, C. Baliski, R. Irvine, D. Anderson, G. Wilkins et al., Hemithyroidectomy: The Optimal Initial Surgical Approach for Individuals Undergoing Surgery for a Cytological Diagnosis of Follicular Neoplasm, Annals of Surgical Oncology, vol.240, issue.3, pp.425-457, 2006.
DOI : 10.1159/000326594

S. Sciacchitano, L. Lavra, A. Ulivieri, F. Magi, P. D. Francesco et al., Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology, Oncotarget, 2017.
DOI : 10.18632/oncotarget.17220

D. De-roy-van-zuidewijn, I. Songun, J. Hamming, J. Kievit, C. Van-de-velde et al., Preoperative diagnostic tests for operable thyroid disease, World Journal of Surgery, vol.45, issue.4, 1994.
DOI : 10.1007/BF00353749

F. Maia and D. Zantut-wittmann, Thyroid nodule management: clinical, ultrasound and cytopathological parameters for predicting malignancy. Clin Sao Paulo Braz, pp.945-54, 2012.
DOI : 10.6061/clinics/2012(08)15

URL : https://doi.org/10.6061/clinics/2012(08)15

J. Brito, M. Gionfriddo, A. Nofal, A. Boehmer, K. Leppin et al., The Accuracy of Thyroid Nodule Ultrasound to Predict Thyroid Cancer: Systematic Review and Meta-Analysis, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.4, pp.1253-63
DOI : 10.1210/jc.2013-2928

N. Sharon and H. Lis, Lectins: cell-agglutinating and sugar-specific proteins. Science, pp.949-59, 1972.
DOI : 10.1126/science.177.4053.949

K. Drickamer, Two distinct classes of carbohydrate-recognition domains in animal lectins, J Biol Chem. Jul, vol.15263, issue.20, pp.9557-60, 1988.

S. Barondes, V. Castronovo, D. Cooper, R. Cummings, K. Drickamer et al., Galectins: A family of animal ??-galactoside-binding lectins, Cell, vol.76, issue.4, pp.597-605, 1994.
DOI : 10.1016/0092-8674(94)90498-7

S. Barondes, D. Cooper, M. Gitt, H. Leffler, and . Galectins, Structure and function of a large family of animal lectins, J Biol Chem, vol.269, issue.33, pp.20807-20817, 1994.

R. Hughes, The galectin family of mammalian carbohydrate-binding molecules, Biochemical Society Transactions, vol.25, issue.4, pp.1194-1202, 1997.
DOI : 10.1042/bst0251194

M. Gitt, C. Colnot, F. Poirier, K. Nani, S. Barondes et al., Galectin-4 and Galectin-6 Are Two Closely Related Lectins Expressed in Mouse Gastrointestinal Tract, Journal of Biological Chemistry, vol.267, issue.5
DOI : 10.1016/0166-6851(94)90081-7

URL : http://www.jbc.org/content/273/5/2954.full.pdf

Y. Hadari, K. Paz, R. Dekel, T. Mestrovic, D. Accili et al., Galectin-8. A new rat lectin, related to galectin-4, J Biol Chem. Feb, vol.17270, issue.7, pp.3447-53, 1995.
DOI : 10.1074/jbc.270.7.3447

Z. Su, J. Lin, R. Shen, P. Fisher, N. Goldstein et al., Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family., Proceedings of the National Academy of Sciences, vol.93, issue.14, 1996.
DOI : 10.1073/pnas.93.14.7252

J. Wada and Y. Kanwar, Identification and characterization of galectin-9, a novel betagalactoside-binding mammalian lectin, J Biol Chem. Feb, vol.28272, issue.9, pp.6078-86, 1997.

O. Türeci, H. Schmitt, N. Fadle, M. Pfreundschuh, and U. Sahin, Molecular Definition of a Novel Human Galectin Which Is Immunogenic in Patients with Hodgkin's Disease, Journal of Biological Chemistry, vol.22, issue.10, pp.6416-6438, 1997.
DOI : 10.1007/BF00402503

K. Dyer, J. Handen, and H. Rosenberg, The Genomic Structure of the Human Charcot???Leyden Crystal Protein Gene Is Analogous to Those of the Galectin Genes, Genomics, vol.40, issue.2, pp.217-238, 1997.
DOI : 10.1006/geno.1996.4590

B. Cherayil, S. Chaitovitz, C. Wong, and S. Pillai, Molecular cloning of a human macrophage lectin specific for galactose., Proceedings of the National Academy of Sciences, vol.87, issue.18, 1990.
DOI : 10.1073/pnas.87.18.7324

A. Raz, P. Carmi, T. Raz, V. Hogan, A. Mohamed et al., Molecular cloning and chromosomal mapping of a human galactoside-binding protein. Cancer Res, 1991.

C. Brewer, Cross-Linking Activities of Galectins and Other Multivalent Lectins., Trends in Glycoscience and Glycotechnology, vol.9, issue.45, pp.155-65, 1997.
DOI : 10.4052/tigg.9.155

K. Pace and L. Baum, Identification and characterization of T cell surface-counterreceptors for galectin-1, Glycobiology, vol.745, 1996.

R. Yang, D. Hsu, and F. Liu, Expression of galectin-3 modulates T-cell growth and apoptosis., Proceedings of the National Academy of Sciences, vol.93, issue.13, pp.6737-6779, 1996.
DOI : 10.1073/pnas.93.13.6737

F. Liu, S-type mammalian lectins in allergic inflammation, Immunology Today, vol.14, issue.10, 1993.
DOI : 10.1016/0167-5699(93)90263-K

L. Wang, H. Inohara, K. Pienta, and A. Raz, Galectin-3 Is a Nuclear Matrix Protein Which Binds RNA, Biochemical and Biophysical Research Communications, vol.217, issue.1, pp.292-303, 1995.
DOI : 10.1006/bbrc.1995.2777

H. Offner, B. Celnik, T. Bringman, G. Casentini, D. Borocz et al., Recombinant human beta-galactoside binding protein suppresses clinical and histological signs of experimental auto-immune encephalomyelitis, Neuroimmunol, 1990.

S. Sato and R. Hughes, Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages, J Biol Chem. Feb, vol.11269, issue.6, pp.4424-4454, 1994.

S. Dagher, J. Wang, and R. Patterson, Identification of galectin-3 as a factor in premRNA splicing, Proc Natl Acad Sci Feb, vol.1492, issue.4, pp.1213-1220, 1995.

A. Vyakarnam, S. Dagher, J. Wang, and R. Patterson, Evidence for a role for galectin-1 in pre-mRNA splicing., Molecular and Cellular Biology, vol.17, issue.8, pp.4730-4737, 1997.
DOI : 10.1128/MCB.17.8.4730

J. Ochieng, M. Leite-browning, and P. Warfield, Regulation of Cellular Adhesion to Extracellular Matrix Proteins by Galectin-3, Biochemical and Biophysical Research Communications, vol.246, issue.3, pp.788-91, 1998.
DOI : 10.1006/bbrc.1998.8708

F. Poirier and E. Robertson, Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Dev Camb Engl, pp.1229-1265, 1993.

R. Mody, S. Joshi, and W. Chaney, Use of lectins as diagnostic and therapeutic tools for cancer, Journal of Pharmacological and Toxicological Methods, vol.33, issue.1, pp.1-10, 1995.
DOI : 10.1016/1056-8719(94)00052-6

B. Desrues, F. Brichory, H. Léna, P. Bourguet, P. Delaval et al., Treatment of human lung carcinoma xenografts with a combination of 131I-labelled monoclonal antibody Po66 and doxorubicin, Cancer Immunol Immunother CII, 1996.

I. Moutsatsos, M. Wade, M. Schindler, and J. Wang, Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts., Proceedings of the National Academy of Sciences, vol.84, issue.18, pp.6452-6458, 1987.
DOI : 10.1073/pnas.84.18.6452

N. Agrwal, J. Wang, and P. Voss, Carbohydrate-binding protein 35. Levels of transcription and mRNA accumulation in quiescent and proliferating cells, J Biol Chem, vol.264, issue.29, pp.17236-17278, 1989.

K. Yamaoka, S. Ohno, H. Kawasaki, and K. Suzuki, Overexpression of a ??-galactoside binding protein causes transformation of BALB3T3 fibroblast cells, Biochemical and Biophysical Research Communications, vol.179, issue.1, pp.272-281, 1991.
DOI : 10.1016/0006-291X(91)91365-J

R. Bresalier, N. Mazurek, L. Sternberg, J. Byrd, C. Yunker et al., Metastasis of human colon cancer is altered by modifying expression of the ??-galactoside-binding protein galectin 3, Gastroenterology, vol.115, issue.2, pp.287-96, 1998.
DOI : 10.1016/S0016-5085(98)70195-7

L. Marer, N. Hughes, and R. , Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells, Journal of Cellular Physiology, vol.265, issue.1, 1996.
DOI : 10.1002/path.1711450308

H. Inohara, S. Akahani, and A. Raz, Galectin-3 Stimulates Cell Proliferation, Experimental Cell Research, vol.245, issue.2, pp.294-302, 1998.
DOI : 10.1006/excr.1998.4253

T. Irimura, Y. Matsushita, R. Sutton, D. Carralero, D. Ohannesian et al., Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages, Cancer Res, vol.51, issue.1, pp.387-93, 1991.

R. Lotan, Y. Matsushita, D. Ohannesian, D. Carralero, D. Ota et al., Lactose-binding lectin expression in human colorectal carcinomas. Relation to tumor progression, Carbohydrate Research, vol.213, pp.47-57, 1991.
DOI : 10.1016/S0008-6215(00)90597-4

H. Schoeppner, A. Raz, S. Ho, and R. Bresalier, Expression of an endogenous galactosebinding lectin correlates with neoplastic progression in the colon. Cancer, Jun, vol.1575, issue.12, pp.2818-2844, 1995.

M. Nakamura, H. Inufusa, T. Adachi, M. Aga, M. Kurimoto et al., Involvement of galectin-3 expression in colorectal cancer progression and metastasis., International Journal of Oncology, vol.15, issue.1, pp.143-151, 1999.
DOI : 10.3892/ijo.15.1.143

K. Konstantinov, B. Robbins, and F. Liu, Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma, Am J Pathol, 1996.

R. Bresalier, P. Yan, J. Byrd, R. Lotan, and A. Raz, Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system, Cancer, vol.124, issue.4, pp.776-87, 1997.
DOI : 10.1002/(SICI)1097-0142(19970815)80:4<776::AID-CNCR17>3.0.CO;2-Q

X. Xu, A. Naggar, and R. Lotan, Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications, Am J Pathol, 1995.

L. Chiariotti, M. Berlingieri, C. Battaglia, G. Benvenuto, M. Martelli et al., Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumors, International Journal of Cancer, vol.179, issue.3, pp.171-176, 1995.
DOI : 10.1177/29.4.6166661

P. Fernández, M. Merino, M. Gómez, E. Campo, T. Medina et al., GALECTIN-3 AND LAMININ EXPRESSION IN NEOPLASTIC AND NON-NEOPLASTIC THYROID TISSUE, The Journal of Pathology, vol.23, issue.1
DOI : 10.1093/ajcp/61.5.680

A. Gasbarri, M. Martegani, D. Prete, F. Lucante, T. Natali et al., Galectin-3 and CD44v6 Isoforms in the Preoperative Evaluation of Thyroid Nodules, Journal of Clinical Oncology, vol.17, issue.11, pp.3494-502, 1999.
DOI : 10.1200/JCO.1999.17.11.3494

H. Inohara, Y. Honjo, T. Yoshii, S. Akahani, J. Yoshida et al., Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer, pp.2475-84, 1999.

S. Saussez, F. Lorfevre, T. Lequeux, G. Laurent, G. Chantrain et al., The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy, Oral Oncology, vol.44, issue.1, pp.86-93, 2008.
DOI : 10.1016/j.oraloncology.2006.12.014

T. I?i?, S. Savin, D. Cveji?, I. Mare?ko, S. Tati? et al., Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors, Journal of Cancer Research and Clinical Oncology, vol.29, issue.12, pp.1805-1817, 2010.
DOI : 10.1177/002215540305100409

F. Makki, S. Taylor, A. Shahnavaz, A. Leslie, J. Gallant et al., Serum biomarkers of papillary thyroid cancer, Journal of Otolaryngology - Head and Neck Surgery, vol.42, issue.1, p.16, 2013.
DOI : 10.1002/jso.21844

N. Perillo, M. Marcus, and L. Baum, Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death, Journal of Molecular Medicine, vol.76, issue.6, pp.402-414, 1998.
DOI : 10.1007/s001090050232

S. Savin, D. Cveji?, and M. Jankovi?, Expression of Galectin-1 and Galectin-3 in Human Fetal Thyroid Gland, Journal of Histochemistry & Cytochemistry, vol.183, issue.4, 2003.
DOI : 10.1007/BF00187901

A. Bartolazzi, F. Orlandi, E. Saggiorato, M. Volante, F. Arecco et al., Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study, The Lancet Oncology, vol.9, issue.6, pp.543-552, 2008.
DOI : 10.1016/S1470-2045(08)70132-3

A. Bartolazzi, C. Bellotti, and S. Sciacchitano, Methodology and Technical Requirements of the Galectin-3 Test for the Preoperative Characterization of Thyroid Nodules, Applied Immunohistochemistry & Molecular Morphology, vol.20, issue.1, pp.2-7
DOI : 10.1097/PAI.0b013e31821ee9bb

F. Liu and G. Rabinovich, Galectins as modulators of tumour progression, Nature Reviews Cancer, vol.19, issue.1, pp.29-41, 2005.
DOI : 10.1038/nrc1275

Y. Takenaka, H. Inohara, T. Yoshii, K. Oshima, S. Nakahara et al., Malignant transformation of thyroid follicular cells by galectin-3. Cancer Lett, pp.111-120, 2003.

T. Yoshii, H. Inohara, Y. Takenaka, Y. Honjo, S. Akahani et al., Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells, International Journal of Oncology
DOI : 10.3892/ijo.18.4.787

T. Yoshii, H. Inohara, Y. Takenaka, Y. Honjo, S. Akahani et al., Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells, International Journal of Oncology, vol.18, issue.4, pp.787-92, 2001.
DOI : 10.3892/ijo.18.4.787

S. Akahani, P. Nangia-makker, H. Inohara, H. Kim, and A. Raz, Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res, pp.5272-5278, 1997.

A. Bartolazzi, A. Gasbarri, M. Papotti, G. Bussolati, T. Lucante et al., Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions, The Lancet, vol.357, issue.9269, pp.1644-50, 2001.
DOI : 10.1016/S0140-6736(00)04817-0

E. Saggiorato, S. Cappia, D. Giuli, P. Mussa, A. Pancani et al., Galectin-3 as a Presurgical Immunocytodiagnostic Marker of Minimally Invasive Follicular Thyroid Carcinoma, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.11, pp.5152-5160, 2001.
DOI : 10.1210/jcem.86.11.8043

L. De-matos, D. Giglio, A. Matsubayashi, C. De-lima-farah, M. et al., Expression of ck-19, galectin-3 and hbme-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis, Diagnostic Pathology, vol.7, issue.1, p.97, 2012.
DOI : 10.1002/dc.20841

M. Xing, B. Haugen, and M. Schlumberger, Progress in molecular-based management of differentiated thyroid cancer, The Lancet, vol.381, issue.9871, pp.1058-69, 2013.
DOI : 10.1016/S0140-6736(13)60109-9

S. Sciacchitano, L. Lavra, A. Ulivieri, F. Magi, T. Porcelli et al., Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3